scorecardresearch
Thursday, July 24, 2025
TopicBreast cancer

Topic: breast cancer

5-yr breast cancer survival rate a dismal 66.4% in India with regional disparity, finds ICMR-led study

The study, published in American Cancer Society Journal, shows survival rate 5 yrs after diagnosis ranges from 41.9% in Pasighat to 74.9% in Mizoram. In countries like US, it's over 90%.

On dead patient’s plea, HC asks Centre for ‘best option’ to make affordable breast cancer meds available

Directive comes on 2022 plea filed by patient seeking Kerala HC's intervention to urge govt to help slash price of a critical cancer drug. She died during the course of the case.

Novartis, Eli Lilly oppose compulsory licences for breast cancer drugs, say sales up despite price

Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.

Cancer cases in under-50s rises by nearly 80% worldwide in last 30 years, finds BMJ study

The research found that the fastest rise was in windpipe and prostate cancers while the heaviest death toll was seen for cancers of breast, windpipe, lung, bowel, and stomach.

Asian women at higher risk of breast & cervical cancers; India lacks elimination targets: Study

Asia was also found to have the world's highest death rate from cervical cancer, with more than 58 per cent related to it.

Glenmark slashes price of HER2-positive breast cancer drug Trumab by 70%, making it cheapest in India

Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.

Why women with stage 4 breast cancer deserve more than unrelatable pink ribbons

Many women with metastatic breast cancer feel that little is done to showcase the less optimistic and more frightening aspects of the disease.

Experimental drug shows success in advanced breast cancer patients, better than standard chemo

Trastuzumab deruxtecan helped check cancer growth in even those with low levels of protein that cancer drugs target. Tumours didn't grow for at least 10 months, compared to average 5 in chemotherapy.

Rise of breast cancer in Indian women is alarming but expected. It’s your ‘Western’ diet

If news of breast cancer cases rising among women is shocking, it's time to leave your 'inflammatory diet'. Here's a healthier model.

1 in 7 women aged 50-74 who undergo mammogram ‘overdiagnosed’ for breast cancer, finds US study

US study looked at nearly 36,000 women who underwent screening & found that in many cases pre-cancers may not have grown into full malignancy before the women died of other causes.

On Camera

Defence, tech, education—Modi’s visit will boost India-UK ties

Given the immediate challenges on India’s borders, cooperation in the defence sector with partners such as the UK has achieved greater importance.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.